Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-2333Ms in Recurrent Major Depressive Disorder
NCT00514865Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jun 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ONO-2333Ms in major depressive disorder (MDD), sponsored by Ono Pharmaceutical. Started Jun 2007; status: completed.
02
Drugs
ONO-2333Ms
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00514865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514865.